About The Native Antigen Company
From its humble beginnings in 2010, The Native Antigen Company has become one of the world’s leading suppliers of reagents, that enable research into vaccine development and diagnostics for emerging and endemic infectious diseases. We specialise in the development and manufacture of native and recombinant viral and bacterial antigens, antibodies and immunoassays, alongside bespoke product development and custom manufacturing using proprietary mammalian cell expression system VirtuE™, which are critical component requirements for diagnostic (IVD), pharmaceutical and academic sectors.
The Native Antigen Company’s team have decades of experience in the isolation and purification of native antigens and high-yield mammalian cell expression systems, ensuring conformity to native type. The Company’s high-quality reagents have been widely adopted by leading pharmaceutical, in vitro diagnostic assay manufacturers, and academic groups in cutting-edge vaccine research and serology, where correct folding and glycosylation are vital. We are proud to be one of the first companies globally to offer antigens for SARS-CoV-2 and continue to play an important role in supporting the global response to the COVID-19 pandemic.
We understand that agility matters, maintaining strong relationships with industry and academia to maximise our responsiveness and ensure a reliable and excellent service. Building on our recognised expertise in infectious diseases, we are expanding our portfolio to include a range of disease-state markers and other critical reagents for human health.
Our products and Services:
Contract and Custom Services
With decades of experience in the field of recombinant protein production and assay development, The Native Antigen Company can undertake a range of custom projects on your behalf, such as Vector design, Protein expression, Protein purification, Antibody generation, ELISA development, and Virology testing. We have established systems to ensure that our clients are fully informed of their project’s progress. During a project you will have direct access to the R&D team, who provide regular updates on progress.
Antigens and Antibody production
By utilising our VirtuE™, mammalian expression system, we have developed an extensive range of products for infectious disease research and development, and particularly for use in the manufacturing of immunoassays in the IVD sector, and for vaccine research in the biopharmaceutical sector. Our product portfolios include antigens, antibodies and virus-like particles and toxins.
A range of viral and bacterial research-use immunoassays. Our immunoassays for Zika virus offer a high degree of specificity and sensitivity. We also have assays to detect the serological response to infections, and to measure levels of Zika NS1 protein during an infection.